Factors associated with left ventricular mass during disease modifying antirheumatic drug therapy in patients with rheumatoid arthritis: the Joint Heart study
In patients with RA on DMARD treatment, the mean LV mass index remained stable during 22 months of follow-up. Obesity was the strongest factor associated with higher LV mass index, while use of bDMARD throughout the study period was associated with lower LV mass index.
Authors
- Bjørg‐Tilde Svanes Fevang (ORCID: https://orcid.org/0000-0001-6957-8730)
- Arve Ulvik (ORCID: https://orcid.org/0000-0003-1574-9690)
- Helga Midtbø (ORCID: https://orcid.org/0000-0002-3558-9914)
- Per Magne Ueland (ORCID: https://orcid.org/0000-0002-1903-0571)
- Klaus Meyer (ORCID: https://orcid.org/0000-0002-2145-7777)
- Ester Kringeland (ORCID: https://orcid.org/0000-0002-9015-741X)
- Anja Linde (ORCID: https://orcid.org/0000-0002-6330-0364)
- Eva Gerdts (ORCID: https://orcid.org/0000-0003-4109-2311)
Institutions
- Oslo University Hospital (NO)
- Haukeland University Hospital (NO)
- NORCE Research AS (NO)
- Bevital (Norway) (NO)
- University of Bergen (NO)
Publication Details
- Journal
- International Journal of Cardiology Cardiovascular Risk and Prevention
- Published
- 2025-10-04
- DOI
- https://doi.org/10.1016/j.ijcrp.2025.200521
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00